On May 6, 2021, Nikkei Biotechnology&Business was introduced the report article of the research results.

May 6, 2021 Nikkei Biotechnology&Business introduced an article in which the research team of Etsuko Miyamoto-Sato, a professor at the Tokyo University of Science Research Institute, who is also a director of our company, reported the research results to bioRxiv.